The first study to test the gene-editing technology CRISPR inside the human body is about to get underway in the United States, according to news reports. Read more in livescience.com
Author Archives: biocon
On Monday, July 29, we will be 209 days into the calendar year. And we will have used up all the resources the Earth could regenerate in 365 days. Read more in weforum.org
Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the body to try to cure an inherited form of blindness. Read more in SpectrumNews
The human body is home to trillions of microorganisms that have direct and indirect impacts on health and disease. The microbiota that resides on and within us is a diverse community of bacteria, archaea, viruses, and fungi. Read more in nature.com
The research could eventually lead to new sources of organs for transplant, but ethical and technical hurdles need to be overcome. Read more in nature.com
After several high-profile cases, the country’s government is creating a board to oversee and investigate all serious allegations of scientific misconduct. Read more in the-scientist.com
Scary new life-threatening fungal infections could soon menace mankind, thanks to climate change, a new report argues. Read more in webmd.com
During the period 6-13 July 2019, the students of the IHU MSc in Bioeconomy: Biotechnology and Law, had the unique opportunity to visit the beautiful city of Ghent, as well as other cities of Belgium, such as Brussels and Antwerp. The BioContact Training included: Guidance by the biosafety experts of Perseus company in the research […]
On 25th July 2018, the Court of Justice of the European Union ruled that the regulatory framework for genetic engineering should be extended to recently developed methods of gene editing. The European Federation of Biotechnology regrets this ruling because it ignores scientific arguments that the interpretations of the technologies are scientifically inaccurate. Read more on […]
The devastating outbreak of the disease that has led to millions of pig deaths in East Asia has intensified efforts to develop a vaccine quickly, but the virus presents several challenges that are yet to be overcome. Read more in the-scientist.com